phrykt

Amgen (AMGN) debt: $54.6B

Amgen had $54.6B of long-term debt on Dec 31, 2025, including the part due within a year, down 9.1% from $60.1B a year earlier.

From Amgen's filings with the SEC · Read the filing · AMGN stock page

Amgen debt by year

$33.3B2021$38.9B2022$64.6B2023$60.1B2024$54.6B2025

#22 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$54.6B-9%
Dec 31, 2024$60.1B-7%
Dec 31, 2023$64.6B+66%
Dec 31, 2022$38.9B+17%
Dec 31, 2021$33.3B–

Debt of similar companies

Companies in the same industry as Amgen, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Amgen$54.6BDec 31, 2025
Gilead Sciences$24.9BDec 31, 2025
Biogen$6.3BDec 31, 2025
Halozyme Therapeutics$2.1BDec 31, 2025
Qiagen$1.7BDec 31, 2025
Moderna$590MDec 31, 2025
Repligen$542MDec 31, 2025

Questions and answers

What is Amgen's debt?

Amgen had $54.6B of long-term debt on Dec 31, 2025, including the part due within a year, down 9.1% from $60.1B a year earlier.

Numbers as reported in Amgen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology